L. Lawson

Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities

Sue Ann Chan, F. Hussain, L. Lawson, 2013, The Journal of dermatological treatment.

Clinical impact of antibodies against ustekinumab in psoriasis: an observational, cross-sectional, multicenter study.

R. Emsley, M. Barnes, K. Payne, 2020, The Journal of investigative dermatology.

Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies

H. Ali, A. Burden, C. Griffiths, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Using Real‐World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study

R. Emsley, M. Barnes, K. Payne, 2020, Clinical and translational science.

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma

M. Nicolson, I. Depasquale, F. Meredith, 2022, Frontiers in Immunology.

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

M. Rutter, A. Burden, N. Reynolds, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength

R. Emsley, K. Payne, D. Stocken, 2017, The Journal of investigative dermatology.

Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength

K. Payne, D. Stocken, L. Cordingley, 2017, The Journal of investigative dermatology.

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

M. Lunt, D. Ashcroft, M. Augustin, 2019, The British journal of dermatology.